Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Comparison of complement activation between tuberculous and malignant pleuritis]

K Hidaka1, M Abe, T Tanaka

  • 1Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Nihon Kyobu Shikkan Gakkai Zasshi
|April 1, 1995
PubMed
Summary

Complement activation product SC5b-9 is significantly higher in tuberculous pleural effusions than malignant ones, suggesting a key role in tuberculosis pleuritis. This finding aids in differentiating causes of pleural effusions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diurnal changes in the stomatal, mesophyll, and biochemical limitations of photosynthesis in well-watered greenhouse-grown strawberries.

Photosynthetica·2024
Same author

HIF-2α Inhibits Ameloblast Differentiation via Hey2 in Tooth Development.

Journal of dental research·2022
Same author

Talbot interferometry for imaging two-dimensional electron density distribution over discharge plasma with higher sensitivity.

The Review of scientific instruments·2019
Same author

A metagenetic approach for revealing community structure of marine planktonic copepods.

Molecular ecology resources·2014
Same author

Activation of the human multidrug resistance-1 (mdr1) gene promoter in response to inhibitors of DNA topoisomerases.

International journal of oncology·2011
Same author

Central glial activation mediates cancer-induced pain in a rat facial cancer model.

Neuroscience·2011

Area of Science:

  • Immunology
  • Pulmonology
  • Pathology

Background:

  • Pleural effusions are challenging to diagnose, with tuberculous and malignant causes being common.
  • Understanding the underlying mechanisms, such as complement activation, can improve differential diagnosis.
  • Complement activation products may serve as biomarkers for specific pleural effusion types.

Purpose of the Study:

  • To investigate the role of complement activation products in distinguishing between tuberculous and malignant pleural effusions.
  • To analyze specific complement activation products, including SC5b-9, Bb, and C4d, in different pleural effusion types.
  • To correlate complement activation markers with tissue damage markers like LDH.

Main Methods:

  • Measurement of complement activation products (SC5b-9, Bb, C4d) and immune complexes in pleural effusion samples.

Related Experiment Videos

  • Quantification of lactate dehydrogenase (LDH) as a marker of tissue damage.
  • Statistical analysis to compare levels between tuberculous and malignant effusions and assess correlations.

    • Main Results:

    • Pleural SC5b-9 levels were significantly higher in tuberculous effusions compared to malignant effusions.
    • In tuberculous effusions, SC5b-9 correlated significantly with LDH and Bb, but not with C4d or immune complexes.
    • In malignant effusions, SC5b-9 and Bb levels were low and showed no significant correlation with each other or LDH.

    Conclusions:

    • Complement activation, particularly via the common pathway indicated by SC5b-9, plays a significant role in the pathogenesis of tuberculous pleuritis.
    • The observed correlations in tuberculous effusions suggest an active inflammatory and tissue-damaging process involving complement.
    • Complement activation does not appear to play a significant role in malignant pleuritis, indicating different underlying mechanisms.